The Mynx Product Family of Vascular Closure Devices represent a new approach to vascular closure by using targeted placement of the Mynx Sealant, which is composed of polyethylene glycol (PEG). PEG is a water-soluble, bio-inert, non-thrombogenic polymer known for its well-established safety profile and broad use in the medical field. PEG is used in products such as gel caps and cranial sealing (Duraseal™, Covidien).

 

The Original Mynx Sealant

The original Mynx Sealant consists of freeze-dried polyethylene glycol (PEG). Immediately upon placement of the Mynx Sealant on the arteriotomy, blood infiltrates the porous structure and the sealant expands to three to four times its size*. When fully expanded, the sealant consists of 95% blood and fluids and 5% PEG sealant.

 

 

As blood collects within the porous matrix, the coagulation produces a durable hemostasis and platform for natural vessel healing. Within 30 days, the sealant is absorbed by the body, leaving nothing behind but a healed artery.

 

 

Introducing Grip Technology: Grip Technology is a new configuration of the PEG sealant that mechanically grips the artery. When combined with the original Mynx Sealant, Grip Technology achieves secure extravascular hemostasis, dissolving within 30 days and leaving nothing behind but a healed artery.

 

The MynxGrip Sealant

The MynxGrip Sealant is comprised of two configurations of polyethylene glycol (PEG), the Grip Tip and the original Mynx Sealant.

 

Grip Technology and the Grip Tip
The Grip Tip is a new configuration of PEG, developed using our proprietary Grip Technology, which allows the sealant to mechanically adhere to the artery wall.

 

Once the MynxGrip Sealant enters the tissue tract, the body’s temperature and pH level cause the Grip Tip to soften and interlock with the contours of the vessel wall, effectively gripping the artery and providing secure closure.

 

 

Simultaneously, the porous structure of the Mynx Sealant absorbs blood and subcutaneous fluids, swelling three to four times its original size and filling the tissue tract.

 

The Result: Secure extravascular closure.

 

 

* Data on file with AccessClosure, Inc.